These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 12683743)

  • 21. Brazilian response to the human immunodeficiency virus/acquired immunodeficiency syndrome epidemic among injection drug users.
    Mesquita F; Doneda D; Gandolfi D; Nemes MI; Andrade T; Bueno R; Piconez e Trigueiros D
    Clin Infect Dis; 2003 Dec; 37 Suppl 5():S382-5. PubMed ID: 14648452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Demographic, HIV risk behavior, and health status characteristics of "crack" cocaine injectors compared to other injection drug users in three New England cities.
    Buchanan D; Tooze JA; Shaw S; Kinzly M; Heimer R; Singer M
    Drug Alcohol Depend; 2006 Feb; 81(3):221-9. PubMed ID: 16171952
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of education on overall and cause-specific mortality in injecting drug users, according to HIV and introduction of HAART.
    Jarrin I; Lumbreras B; Ferreros I; Pérez-Hoyos S; Hurtado I; Hernández-Aguado I
    Int J Epidemiol; 2007 Feb; 36(1):187-94. PubMed ID: 17085455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psychosocial antecedents of needle/syringe disinfection by drug users: a theory-based prospective analysis.
    Longshore D; Stein JA; Anglin MD
    AIDS Educ Prev; 1997 Oct; 9(5):442-59. PubMed ID: 9391659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV risk behavior among injection drug users in Tehran, Iran.
    Razani N; Mohraz M; Kheirandish P; Malekinejad M; Malekafzali H; Mokri A; McFarland W; Rutherford G
    Addiction; 2007 Sep; 102(9):1472-82. PubMed ID: 17645427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuropsychological impairment among asymptomatic HIV-positive former intravenous drug users.
    Rodríguez Salgado D; Rodríguez Alvarez M; Seoane Pesqueira G
    Cogn Behav Neurol; 2006 Jun; 19(2):95-104. PubMed ID: 16783132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV infection and high-risk behaviors in opioid dependent patients: the Indian context.
    Vaswani M; Desai NG
    Addict Behav; 2004 Nov; 29(8):1699-705. PubMed ID: 15451140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of changes in perceived self-efficacy on HIV risk behaviors over time.
    Kang SY; Deren S; Andia J; Colón HM; Robles R
    Addict Behav; 2004 May; 29(3):567-74. PubMed ID: 15050674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Harm reduction interventions, behaviours and associated health outcomes in France, 1996-2003.
    Emmanuelli J; Desenclos JC
    Addiction; 2005 Nov; 100(11):1690-700. PubMed ID: 16277629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Injection drug use and crack cocaine smoking: independent and dual risk behaviors for HIV infection.
    McCoy CB; Lai S; Metsch LR; Messiah SE; Zhao W
    Ann Epidemiol; 2004 Sep; 14(8):535-42. PubMed ID: 15350952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV prevalence and factors associated with HIV infection among male injection drug users under 30: a cross-sectional study in Long An, Vietnam.
    Tran TM; Nguyen HT; Yatsuya H; Hamajima N; Nishimura A; Ito K
    BMC Public Health; 2006 Oct; 6():248. PubMed ID: 17029648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Poverty and HIV seropositivity: the poor are more likely to be infected.
    Krueger LE; Wood RW; Diehr PH; Maxwell CL
    AIDS; 1990 Aug; 4(8):811-4. PubMed ID: 2261136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Demographic characteristics and risk behaviors associated with HIV positive injecting drug users in Xinjiang, China.
    Zhang Y; Shan H; Trizzino J; Ruan Y; Beauchamp G; Mâsse B; Ma J; Gu Y; He Y; Rui B; Wang J; Poundstone K; Jiang Y; Brooks Jackson J; Shao Y
    J Infect; 2007 Mar; 54(3):285-90. PubMed ID: 16831464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users.
    Van Den Berg C; Smit C; Van Brussel G; Coutinho R; Prins M;
    Addiction; 2007 Sep; 102(9):1454-62. PubMed ID: 17697278
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Social context of needle selling in Baltimore, Maryland.
    Latkin CA; Davey MA; Hua W
    Subst Use Misuse; 2006; 41(6-7):901-13. PubMed ID: 16809178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Co-occurrence of treatment nonadherence and continued HIV transmission risk behaviors: implications for positive prevention interventions.
    Kalichman SC
    Psychosom Med; 2008 Jun; 70(5):593-7. PubMed ID: 18519882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Background demographics and risk behaviors of injecting drug users in Karachi, Pakistan.
    Parviz S; Fatmi Z; Altaf A; McCormick JB; Fischer-Hoch S; Rahbar M; Luby S
    Int J Infect Dis; 2006 Sep; 10(5):364-71. PubMed ID: 16793307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development, description, and acceptability of a small-group, behavioral intervention to prevent HIV and hepatitis C virus infections among young adult injection drug users.
    Purcell DW; Garfein RS; Latka MH; Thiede H; Hudson S; Bonner S; Golub ET; Ouellet LJ;
    Drug Alcohol Depend; 2007 Nov; 91 Suppl 1():S73-80. PubMed ID: 17466465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users.
    Garfein RS; Golub ET; Greenberg AE; Hagan H; Hanson DL; Hudson SM; Kapadia F; Latka MH; Ouellet LJ; Purcell DW; Strathdee SA; Thiede H;
    AIDS; 2007 Sep; 21(14):1923-32. PubMed ID: 17721100
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increase in sexual risk behavior associated with immunologic response to highly active antiretroviral therapy among HIV-infected injection drug users.
    Tun W; Gange SJ; Vlahov D; Strathdee SA; Celentano DD
    Clin Infect Dis; 2004 Apr; 38(8):1167-74. PubMed ID: 15095224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.